Malaysian Biotechnology Information Centre

bic.org.my

The Malaysian Biotechnology Information Centre (MABIC) is the first and only NGO that promotes biotechnology in Malaysia and enjoys excellent working relationship with ministries, government agencies, research institutes, universities, trade organizations, embassies and high commissions, media, industry and farmer organizations. MABIC’s mission is to provide scientifically accurate and fact-based resources to all stakeholders and support the government’s efforts in developing the biotechnology sector.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

WILLOW BIOSCIENCES EXPANDS ITS PORTFOLIO WITH A NEW PARTNERED PHARMACEUTICAL PROJECT

Willow Biosciences | June 01, 2022

news image

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable ingredients is pleased to announce today that is has been engaged by a specialty pharmaceutical company (the "Counterparty") to optimize an enzyme vital to the development of a large volume Active Pharmaceutical Ingredient (API) used in nutraceutical and pharmaceu...

Read More

INDUSTRIAL IMPACT

PICTOR ANNOUNCES FUNDING ROUND AFTER SUCCESSFUL LAUNCH IN NEW ZEALAND AND USA OF SARS-COV-2 ANTIBODY TEST

Pictor | December 05, 2022

news image

Pictor, a global leader in immunodiagnostics announced a funding round to help accelerate pipeline product development projects along with market development activities within Australia/New Zealand, the US and Europe for its Human Health and Animal Health portfolios. This follows the recent successful launch of the PictArray™ SARS-CoV-2 IgG Antibody Test through Rako Science in New Zealand and key partners in the US. “The test better informs patients and doctors in det...

Read More

US BIOTECH FIRM DONATING 1.5 MILLION DOSES OF EXPERIMENTAL CORONAVIRUS DRUG

TheHill | April 05, 2020

news image

Gilead Sciences Inc., a U.S. biotechnology firm that develops and commercializes drugs, has rapidly expanded its supply of an experimental coronavirus drug and is prepared to donate 1.5 million doses of it to hospitals dealing with severely ill patients. Gilead CEO Daniel O'Day said in a statement Saturday that the 1.5 million doses of the drug, known as remdesivir, could be part of treatment courses for as many as 140,000 patients. He said the doses were available for "compassionate us...

Read More

BAY AREA BIOTECH INCUBATOR OPENS EXTENSIVE NEW LAB FACILITY, PAVING WAY FOR ENTREPRENEURS AND THEIR INNOVATION

MBC BioLabs | May 11, 2020

news image

Innovation and discovery just got easier for life science entrepreneurs as MBC BioLabs announces the opening of a 30,000 square foot building of incubator lab space in San Carlos, Calif.Built specifically as a life-science incubator space over the past 18 months, the new facility brings cutting-edge lab equipment, infrastructure and services to innovators and entrepreneurs so they can begin their discovery work virtually immediately. This is MBC BioLabs' third campus and its seco...

Read More
news image

MEDICAL

WILLOW BIOSCIENCES EXPANDS ITS PORTFOLIO WITH A NEW PARTNERED PHARMACEUTICAL PROJECT

Willow Biosciences | June 01, 2022

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable ingredients is pleased to announce today that is has been engaged by a specialty pharmaceutical company (the "Counterparty") to optimize an enzyme vital to the development of a large volume Active Pharmaceutical Ingredient (API) used in nutraceutical and pharmaceu...

Read More
news image

INDUSTRIAL IMPACT

PICTOR ANNOUNCES FUNDING ROUND AFTER SUCCESSFUL LAUNCH IN NEW ZEALAND AND USA OF SARS-COV-2 ANTIBODY TEST

Pictor | December 05, 2022

Pictor, a global leader in immunodiagnostics announced a funding round to help accelerate pipeline product development projects along with market development activities within Australia/New Zealand, the US and Europe for its Human Health and Animal Health portfolios. This follows the recent successful launch of the PictArray™ SARS-CoV-2 IgG Antibody Test through Rako Science in New Zealand and key partners in the US. “The test better informs patients and doctors in det...

Read More
news image

US BIOTECH FIRM DONATING 1.5 MILLION DOSES OF EXPERIMENTAL CORONAVIRUS DRUG

TheHill | April 05, 2020

Gilead Sciences Inc., a U.S. biotechnology firm that develops and commercializes drugs, has rapidly expanded its supply of an experimental coronavirus drug and is prepared to donate 1.5 million doses of it to hospitals dealing with severely ill patients. Gilead CEO Daniel O'Day said in a statement Saturday that the 1.5 million doses of the drug, known as remdesivir, could be part of treatment courses for as many as 140,000 patients. He said the doses were available for "compassionate us...

Read More
news image

BAY AREA BIOTECH INCUBATOR OPENS EXTENSIVE NEW LAB FACILITY, PAVING WAY FOR ENTREPRENEURS AND THEIR INNOVATION

MBC BioLabs | May 11, 2020

Innovation and discovery just got easier for life science entrepreneurs as MBC BioLabs announces the opening of a 30,000 square foot building of incubator lab space in San Carlos, Calif.Built specifically as a life-science incubator space over the past 18 months, the new facility brings cutting-edge lab equipment, infrastructure and services to innovators and entrepreneurs so they can begin their discovery work virtually immediately. This is MBC BioLabs' third campus and its seco...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us